Atai Life Sciences N.V.

1.98
-0.06 (-2.94%)
At close: Feb 21, 2025, 3:51 PM

Atai Life Sciences N.V. Income Statement

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 314K 233K 20.38M n/a n/a
Cost of Revenue n/a 168K 47K 24K 6K
Gross Profit 314K 65K 20.33M -24K -6K
Operating Income -125.47M -144.79M -135.81M -104.16M 1.57M
Interest Income 1.85M 548K 205K 71K 23K
Pretax Income -39.29M -135.18M -136.6M -101.81M -17.47M
Net Income -40.22M -141.41M -132.61M -102.12M -17.48M
Selling & General & Admin 63.58M 70.35M 92.75M 80.73M 5.09M
Research & Development 62.2M 74.31M 47.96M 11.41M 3.08M
Other Expenses n/a 9.61M -796K -16.09M 425K
Operating Expenses 125.78M 144.66M 140.7M 92.14M 8.17M
Interest Expense 2.66M 1.92M n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 125.78M 144.66M 140.7M 92.14M 8.17M
Income Tax 1.02M 6.23M -3.99M 305K 2K
Shares Outstanding (Basic) 158.83M 155.72M 160.68M 5.81M 5.42M
Shares Outstanding (Diluted) 158.83M 155.72M 160.68M 5.81M 5.42M
EPS (Basic) -0.25 -0.91 -0.83 -17.57 -3.23
EPS (Diluted) -0.25 -0.91 -0.83 -17.57 -3.23
EBITDA -36.31M -135.01M -120.28M -92.12M -17.47M
Depreciation & Amortization 319K 168K 47K 24K 6K